Treatment of Lupus Nephritis with anti-CD20 Followed by Anti-BAFF: Impact on B Cell Reconstitution, B Cell Subsets, and Autoreactivity

被引：0
|
作者：
Fregoso, Yemil Atisha [1 ]
Malkiel, Susan [1 ]
Harris, Kristina [2 ]
Kanaparthi, Sai [2 ]
Byron, Margie [3 ]
Ding, Linna [4 ]
Smilek, Dawn [5 ]
Wofsy, David [6 ]
Dall'Era, Maria [7 ]
Aranow, Cynthia [1 ]
Diamond, Betty [1 ]
机构：
[1] Feinstein Inst Med Res, Manhasset, NY USA
[2] Immune Tolerance Network, Bethesda, MD USA
[3] Rho Fed Syst Inc, Chapel Hill, NC USA
[4] NIAID, 9000 Rockville Pike, Bethesda, MD 20892 USA
[5] Immune Tolerance Network, San Francisco, CA USA
[6] UCSF, San Francisco, CA USA
[7] Univ Calif San Francisco, San Francisco, CA 94143 USA
来源：
ARTHRITIS & RHEUMATOLOGY | 2019年 / 71卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0941
引用
收藏
页数：4
相关论文
共 50 条
  • [11] Radiolabeled anti-CD20 monoclonal antibodies for the treatment of B-cell lymphoma
    Dillman, RO
    JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (16) : 3545 - 3557
  • [12] Anti-CD20 antibody treatment in refractory Class IV lupus nephritis
    Carroll, Robert P.
    Brown, Fiona
    Kerr, Peter G.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2007, 22 (01) : 291 - 293
  • [13] Anti-CD20 Antibody Therapy for B-Cell Lymphomas
    Maloney, David G.
    NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (09): : 878 - 878
  • [14] Anti-CD20 Antibody Therapy for B-Cell Lymphomas
    Maloney, David G.
    NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (21): : 2008 - 2016
  • [15] Characterization of the B cell response to Leishmania infection after anti-CD20 B cell depletion
    Bockenstedt, Marie M.
    Boggiatto, Paola M.
    Jones, Douglas E.
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2015, 8 (06): : 6192 - 6202
  • [16] Low-Dose Subcutaneous Anti-CD20 Treatment Depletes Disease Relevant B Cell Subsets and Attenuates Neuroinflammation
    Catherine Huck
    David Leppert
    Vanessa Wegert
    Cindy Schmid
    Robert Dunn
    Gisbert Weckbecker
    Paul A. Smith
    Journal of Neuroimmune Pharmacology, 2019, 14 : 709 - 719
  • [17] Effect of Two Anti-CD20 Abs on B Cell Depletion and Reconstitution in Non-Human Primates
    Sun, W.
    O'Neill, N.
    Zhang, T.
    Braileanu, G.
    Reimann, K.
    Pierson, R.
    Azimzadeh, A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2017, 17 : 620 - 620
  • [18] Low-Dose Subcutaneous Anti-CD20 Treatment Depletes Disease Relevant B Cell Subsets and Attenuates Neuroinflammation
    Huck, Catherine
    Leppert, David
    Wegert, Vanessa
    Schmid, Cindy
    Dunn, Robert
    Weckbecker, Gisbert
    Smith, Paul A.
    JOURNAL OF NEUROIMMUNE PHARMACOLOGY, 2019, 14 (04) : 709 - 719
  • [19] Tetravalent anti-CD20/CD3 bispecific antibody for the treatment of B cell lymphoma
    Lu, Chia-Yen
    Chen, Gregory J.
    Tai, Pei-Han
    Yang, Yu-Chen
    Hsu, Yu-Shen
    Chang, Mingi
    Hsu, Chuan-Lung
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2016, 473 (04) : 808 - 813
  • [20] Enhanced anti-B-cell tumor effects with anti-CD20 superantibody - Comments
    Reisfeld, RA
    JOURNAL OF IMMUNOTHERAPY, 2002, 25 (01): : 62 - 62
12345